Inventor
DESCHATELETS PASCAL
US33 patents
⚠️ This page may combine multiple inventors who share the name “DESCHATELETS PASCAL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
APELLIS PHARMACEUTICALS INC
19 patentsUS10308687B2Jun 4, 2019
Cell-penetrating compstatin analogs and uses thereof
APELLIS PHARMACEUTICALS INC14 citations92
US10035822B2Jul 31, 2018
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
APELLIS PHARMACEUTICALS INC15 citations92
US10875893B2Dec 29, 2020
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
APELLIS PHARMACEUTICALS INC10 citations84
US10407466B2Sep 10, 2019
Methods of selecting compstatin mimetics
APELLIS PHARMACEUTICALS INC12 citations84
US11040107B2Jun 22, 2021
Dosing regimens and related compositions and methods
APELLIS PHARMACEUTICALS INC9 citations83
US11903994B2Feb 20, 2024
Dosing regimens
APELLIS PHARMACEUTICALS INC4 citations73
US11292815B2Apr 5, 2022
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
APELLIS PHARMACEUTICALS INC2 citations73
US11013782B2May 25, 2021
Methods of treating chronic disorders with complement inhibitors
APELLIS PHARMACEUTICALS INC1 citations73
US11001610B2May 11, 2021
Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
APELLIS PHARMACEUTICALS INC4 citations73
US12290566B2May 6, 2025
Dosing regimens and related compositions and methods
APELLIS PHARMACEUTICALS INC2 citations72
US11844841B2Dec 19, 2023
Dosing regimens and related compositions and methods
APELLIS PHARMACEUTICALS INC4 citations72
US11407789B2Aug 9, 2022
Cell-penetrating compstatin analogs and uses thereof
APELLIS PHARMACEUTICALS INC2 citations71
US10941184B2Mar 9, 2021
Cell-penetrating compstatin analogs and uses thereof
APELLIS PHARMACEUTICALS INC3 citations71
US11712460B2Aug 1, 2023
Methods of treating chronic disorders with complement inhibitors
APELLIS PHARMACEUTICALS INC0 citations62
US11661441B2May 30, 2023
Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
APELLIS PHARMACEUTICALS INC0 citations62
US11291407B2Apr 5, 2022
Detection of high risk drusen
APELLIS PHARMACEUTICALS INC0 citations62
US12528836B2Jan 20, 2026
Dosing regimens
APELLIS PHARMACEUTICALS INC0 citations61
US12458695B2Nov 4, 2025
Dosing regimens and related compositions and methods
APELLIS PHARMACEUTICALS INC0 citations60
US10696718B2Jun 30, 2020
Compstatin analogs for treatment of neuropathic pain
APELLIS PHARMACEUTICALS INC0 citations52
FRANCOIS CEDRIC
5 patentsUS9421240B2Aug 23, 2016
Compstatin analogs for treatment of neuropathic pain
FRANCOIS CEDRIC41 citations94
US8580735B2Nov 12, 2013
Local complement inhibition for treatment of complement-mediated disorders
FRANCOIS CEDRIC50 citations94
US10125171B2Nov 13, 2018
Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
FRANCOIS CEDRIC16 citations92
US10039802B2Aug 7, 2018
Methods of treating chronic disorders with complement inhibitors
FRANCOIS CEDRIC5 citations84
US8198020B2Jun 12, 2012
Compositions and methods for enhancing phagocytosis or phagocyte activity
FRANCOIS CEDRIC17 citations82